⌘K

Login Start Free

Home/Filings/4/0000950170-24-121206

4//SEC Filing

BB BIOTECH AG 4

Accession 0000950170-24-121206

CIK 0001633932other

View on SEC.gov Company Profile

Filed

Nov 4, 7:00 PM ET

Accepted

Nov 5, 12:06 PM ET

Size

10.4 KB

Accession

0000950170-24-121206

Insider Transaction Report

Form 4

Period: 2024-11-01

ESSA Pharma Inc.EPIX

BIOTECH GROWTH N V

10% Owner

Transactions

Sale
Common Shares
2024-11-01$1.53/sh−2,000,000$3,064,000→ 5,879,583 total
Sale
Common Shares
2024-11-01$1.53/sh−2,000,000$3,058,800→ 1,879,583 total
Sale
Common Shares
2024-11-01$1.51/sh−1,879,583$2,843,809→ 0 total
Sale
Common Shares
2024-11-01$1.53/sh−2,000,000$3,051,800→ 3,879,583 total

10% Owner

Transactions

Sale
Common Shares
2024-11-01$1.53/sh−2,000,000$3,051,800→ 3,879,583 total
Sale
Common Shares
2024-11-01$1.53/sh−2,000,000$3,058,800→ 1,879,583 total
Sale
Common Shares
2024-11-01$1.53/sh−2,000,000$3,064,000→ 5,879,583 total
Sale
Common Shares
2024-11-01$1.51/sh−1,879,583$2,843,809→ 0 total

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

ESSA Pharma Inc.

CIK 0001633932

Entity typeother

IncorporatedSwitzerland

Related Parties

1

filerCIK 0000924223

Filing Metadata

Form type: 4
Filed: Nov 4, 7:00 PM ET
Accepted: Nov 5, 12:06 PM ET
Size: 10.4 KB

View on SEC.gov